Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...
The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback